Hemophilia with Inhibitor
📧 Sign up to get email alerts when something new happens for Hemophilia with Inhibitor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: ITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer Inhibitor [Phase 4]
A Phase 4 trial update evaluating ITI with SCT800 alone or in combination with daratumumab in adolescents and adults with Hemophilia A and h…
-
CLINICAL_TRIALS trial_result · 2021-12-17Clinical Trial Update: Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Hemophilia A or B [Phase 3]
Phase 3 trial of Marzeptacog Alfa (Activated) for Hemophilia A or B with inhibitors was terminated.